MedPath

Clomifene

Generic Name
Clomifene
Brand Names
Clomid
Drug Type
Small Molecule
Chemical Formula
C26H28ClNO
CAS Number
911-45-5
Unique Ingredient Identifier
1HRS458QU2
Background

A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.

Indication

Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.

Associated Conditions
Ovulatory Dysfunction

RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders

Phase 4
Withdrawn
Conditions
Infertility
Interventions
Drug: High dose gonadotropins
First Posted Date
2012-04-13
Last Posted Date
2016-12-16
Lead Sponsor
Weill Medical College of Cornell University
Registration Number
NCT01577199

Metformin for the Treatment of Unexplained Oligozspermia

Phase 4
Conditions
Infertility
Interventions
First Posted Date
2012-02-08
Last Posted Date
2015-08-07
Lead Sponsor
The Egyptian IVF-ET Center
Target Recruit Count
600
Registration Number
NCT01529177
Locations
🇪🇬

The Egyptian IVF-ET center, Cairo, Egypt

Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve

Not Applicable
Completed
Conditions
Infertility
Interventions
First Posted Date
2011-07-08
Last Posted Date
2011-07-12
Lead Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Target Recruit Count
289
Registration Number
NCT01389713
Locations
🇮🇹

Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

Phase 1
Completed
Conditions
Infertility
First Posted Date
2011-04-22
Last Posted Date
2012-12-20
Lead Sponsor
Milton S. Hershey Medical Center
Target Recruit Count
25
Registration Number
NCT01340521
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Differential Effects of Clomiphene Citrate in Women Undergoing Superovulation

Not Applicable
Completed
Conditions
Mood
Interventions
Other: Placebo
First Posted Date
2011-02-07
Last Posted Date
2016-06-28
Lead Sponsor
University of Utah
Target Recruit Count
20
Registration Number
NCT01291056
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene

Phase 1
Completed
Conditions
Disorder Due Cytochrome P450 CYP2D6 Variant
Cytochrome P450 CYP3A Enzyme Deficiency
Anovulation
Interventions
First Posted Date
2011-02-04
Last Posted Date
2015-02-24
Lead Sponsor
Robert Bosch Gesellschaft für Medizinische Forschung mbH
Target Recruit Count
20
Registration Number
NCT01289756
Locations
🇩🇪

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, BW, Germany

Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination

Phase 2
Completed
Conditions
Infertility
Interventions
First Posted Date
2010-11-02
Last Posted Date
2011-07-12
Lead Sponsor
Cairo University
Target Recruit Count
214
Registration Number
NCT01232075
Locations
🇪🇬

Ahmed Elgazzar hospital, Cairo, Egypt

🇪🇬

Cairo university hospital, Cairo, Egypt

The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination

First Posted Date
2010-10-13
Last Posted Date
2014-11-06
Lead Sponsor
Royan Institute
Target Recruit Count
95
Registration Number
NCT01219101
Locations
🇮🇷

Royan Institute, Tehran, Iran, Islamic Republic of

Mild Stimulation Protocol Versus Microdose Gonadotropin-releasing Hormone Agonist Flare up Protocol in Poor Responders

Phase 4
Completed
Conditions
Pregnancy
Interventions
First Posted Date
2010-10-01
Last Posted Date
2010-10-01
Lead Sponsor
Yazd Medical University
Target Recruit Count
159
Registration Number
NCT01213147
Locations
🇮🇷

Yazd Research and Clinical Center for Infertility, Yazd, Iran, Islamic Republic of

Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome

Not Applicable
Completed
Conditions
Polycystic Ovary Syndrome
Interventions
First Posted Date
2010-07-07
Last Posted Date
2010-07-19
Lead Sponsor
Mansoura University
Target Recruit Count
113
Registration Number
NCT01157312
Locations
🇪🇬

Mansoura University Hospitals,OB/GYN department, Mansoura, Dakahlia Governorate, Egypt

© Copyright 2025. All Rights Reserved by MedPath